Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Locations


Orders Processing,
Shipping & Receiving,
Warehouse

2 Shaker Rd Suites
B001/B101
Shirley, MA 01464


Production Lab

Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036

Telephone Numbers



Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565

Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-C196968-100 100 µg $423 
CRD / CRX Antibody - Western Blot analysis of CRX expression in transfected 293T cell line by CRX monoclonal antibody (M01), clone F6-C2.Lane 1: CRX transfected lysate(32.261 KDa).Lane 2: Non-transfected lysate.
CRD / CRX Antibody - Detection limit for recombinant GST tagged CRX is approximately 1 ng/ml as a capture antibody.
CRD / CRX Antibody - Western blot analysis of CRX over-expressed 293 cell line, cotransfected with CRX Validated Chimera RNAi (Lane 2) or non-transfected control (Lane 1). Blot probed with CRX monoclonal antibody (M01), clone F6-C2 . GAPDH ( 36.1 kDa ) used as specificity and loading control.
CRD / CRX Antibody - Western Blot analysis of CRX expression in transfected 293T cell line by CRX monoclonal antibody (M01), clone F6-C2.Lane 1: CRX transfected lysate(32.261 KDa).Lane 2: Non-transfected lysate.
CRD / CRX Antibody - Detection limit for recombinant GST tagged CRX is approximately 1 ng/ml as a capture antibody.
CRD / CRX Antibody - Western blot analysis of CRX over-expressed 293 cell line, cotransfected with CRX Validated Chimera RNAi (Lane 2) or non-transfected control (Lane 1). Blot probed with CRX monoclonal antibody (M01), clone F6-C2 . GAPDH ( 36.1 kDa ) used as specificity and loading control.
1 of 3
2 of 3
3 of 3

Monoclonal Mouse anti‑Human CRD / CRX Antibody (clone F6‑C2, WB) LS‑C196968

Monoclonal Mouse anti‑Human CRD / CRX Antibody (clone F6‑C2, WB) LS‑C196968

Antibody:
CRD / CRX Mouse anti-Human Monoclonal (F6-C2) Antibody
Application:
WB, ELISA, RNAi
Reactivity:
Human
Format:
Unconjugated, Unmodified
Price
Catalog Number
$423
LS-C196968-100
Toll Free North America
206-374-1102
For Research Use Only

Overview

Antibody:
CRD / CRX Mouse anti-Human Monoclonal (F6-C2) Antibody
Application:
WB, ELISA, RNAi
Reactivity:
Human
Format:
Unconjugated, Unmodified

Specifications

Description
CRX antibody LS-C196968 is an unconjugated mouse monoclonal antibody to human CRX (CRD). Validated for ELISA, RNAi and WB.
Target
Human CRD / CRX
Synonyms
CRX | Cone-rod homeobox protein | CRD | LCA7 | OTX3 | Cone-rod homeobox | CORD2 | Orthodenticle homeobox 3
Host
Mouse
Reactivity
Human (tested or 100% immunogen sequence identity)
Clonality
IgG1,k Monoclonal
Clone
F6-C2
Conjugations
Unconjugated
Purification
Purified from ascites by Protein A
Modifications
Unmodified
Immunogen
CRX (AAH16664, aa 1-300 full length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
Specificity
Human CRD / CRX
Applications
  • Western blot
  • ELISA
  • RNA interference
Usage
RNAi Knockdown: Antibody validated. Sandwich ELISA: Recombinant protein. Western Blot: Transfected lysate, Recombinant protein.
Presentation
PBS, pH 7.4
Storage
Store at -20°C or lower. Aliquot to avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About CRD / CRX
O43186 NM_000554 NP_000545.1

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 4/19/2024